Cheap Generics Bring Hope for HIV-Infected

Inter Press Service - September 30, 2005
Marwaan Macan-Markar

http://www.aegis.org/news/ips/2005/IP050912.html

--------------------------------------------------------------------------------
BANGKOK - When the thousands of people living with HIV in Thailand
mark World AIDS Day on Dec.1, they will have reason to smile. No more
will the threat of early death for lack of anti-HIV drugs haunt them.

Such hope stems from the Thai government's decision to offer access to
anti-retroviral (HIV is a retrovirus) medication to all those who need
it under the country's, still young, universal healthcare scheme.

Oct.1 marks the beginning of this initiative, where 10,000 people will
have access to GPO-VIR, the locally-produced generic anti-AIDS drug.
Prior to the expansion of this life-line for HIV patients, an
estimated 50,000 Thais were receiving their regular dose of the
medicine on a quota system.

"This shows that the government is committed to help people with HIV,"
Nimit Tienudom, director of AIDS Access Foundation, an advocacy group,
told IPS. "The people are finally getting their right to medicine".

Under the healthcare system, which was introduced in Thailand soon
after Prime Minister Thaksin Shinawatra's government won its first
term in office in 2001, a patient pays 30 baht (0.75 US cents) for
every visit to the hospital, no matter what his or her ailment is.

During last year's 15th International AIDS Conference, the government
promised to expand coverage to include all those who needed the
life-prolonging anti-retroviral drugs.

But such a commitment -- removing the economic burden that had
prevented those afflicted with AIDS from gaining treatment to live
longer lives --was not the product of benevolence.

"We campaigned for this for four years," adds Nimit. "The pressure on
the government has worked."

In achieving this milestone, Thailand races ahead of other countries
in Asia in caring for people with HIV. It comes at a time when
developing and middle-income countries in this region and other parts
of the developing world are struggling to deliver the desperately
needed anti-AIDS drugs to their citizens.

Just what the world is up against was revealed during World AIDS Day
in 2003, when the World Health Organisation (WHO) and the Joint United
Nations Programme on HIV/AIDS (UNAIDS) launched the '3 by 5' campaign.

The objective was to accelerate the access to affordable anti-AIDS
drugs by ensuring three million people would be on antiretroviral
(ARV) treatment by 2005.

The year this campaign was launched, there were only 440,000 people
across the developing world who were on ARV treatment, out of the six
million people who needed it. The numbing death toll due to
AIDS--three million people every year--was because of a lack of access
to the available drugs.

In Africa, for instance, where live nearly 70 percent of the world's
40 million people with HIV, less than four percent of those who needed
anti-AIDS drugs had access to it, states the WHO.

With only three months left for the '3 by 5' campaign deadline,
countries in Asia with high HIV incidence rates are still far from
meeting their respective targets. But the WHO admits that coverage has
increased, from 50,000 people on treatment in June 2004 to nearly
155,000 people in June this year.

In Cambodia, which has some 123,000 people with HIV, of whom 22,000
need treatment, the WHO was hoping that 10,000 people would be on the
life-saving medication. But a mid-year review revealed that only 7,217
people were on ARVs.

In Burma, which has between 170,000 to 620,000 people with HIV, only
1,500 were receiving treatment of an estimated 46,000 that need it.
The WHO was hoping that 10,000 people would be on medication by
December this year.

Asia's giants China and India also have much road to cover to meet the
end of the year target. China, which has between 430,000 to 1.5
million people with HIV, needs ARV for some 122,000 people. Of that,
only 12,219 people were receiving the drugs and the WHO had set its
sights on between 30,000 to 50,000 people to be on treatment by the
end of the two-year campaign.

"The main reason for Thailand doing so well is that it produces its
own drugs," says Paul Cawthorne, country coordinator of the
humanitarian agency Medecins Sans Frontieres (MSF). "The drugs are
cheap and affordable."

Thailand's public health infrastructure is geared to meet the new
challenge, he added during an interview. "Close to 800 government
hospitals will be involved. But some hospitals in the north will have
bigger burdens because of more HIV cases than those in the south."

Thailand currently has over 600,000 people with HIV, out of a
population of 64 million. Over 300,000 people have died from
AIDS-related disease since the pandemic hit this South-east Asian
country in the early 1980s.

But for activists like Nimit, success is never permanent when battling
a killer like AIDS. He is already setting his sights on more lobbying
to get the Thai government to start producing a new line of cheap,
generic ARVs that would be necessary in three to five years.

By then, say public health experts, many people on the current regimen
of GPO-VIR would have developed a resistance against the drug and
would need a stronger course of treatment.

050930
IP050912

--------------------------------------------------------------------------------
Copyright © 2005 - Inter Press Service. All rights reserved.
Reproduced with permission. Reproduction of this article (other than
one copy for personal reference) must be cleared through the Inter
Press Service, IPS-ONLINE, World Desk via Panisperna 207 00184 Rome,
Italy. Email: info@ips.org  http://www.ips.org

AEGiS is made possible through unrestricted grants from Boehringer
Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers
Squibb Company, Elton John AIDS Foundation, the National Library of
Medicine, and donations from users like you. Always watch for outdated
information. This article first appea red in 2005. This material is
designed to support, not replace, the relationship that exists between
you and your doctor.

AEGiS presents published material, reprinted with permission and
neither endorses nor opposes any material. All information contained
on this website, including information relating to health conditions,
products, and treatments, is for informational purposes only. It is
often presented in summary or aggregate form. It is not meant to be a
substitute for the advice provided by your own physician or other
medical professionals. Always discuss treatment options with a doctor
who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are
protected by copyright as a collective work or compilation under U.S.
copyright and other laws and are the property of AEGiS, or the party
credited as the provider of the content.

To login:http://webboard.aegis.org/WB/?boardID=2
To (un)subscribe: mailto: HIVAIDSNews.list-request@webboard.aegis.org